Liraglutide 00480-3667
Product NDC
00480-3667- Manufacturer
- Teva Pharmaceuticals Usa, Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 24, 2024
- Listing Expires
- December 31, 2027
- Application
- NDA022341
Need to source Liraglutide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Liraglutide | 6 mg/mL |
Drug Class
GLP-1 Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]Glucagon-Like Peptide 1 [CS]
Packaging Options(2)
2 SYRINGE, PLASTIC in 1 CARTON (0480-3667-20) / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19)
3 SYRINGE, PLASTIC in 1 CARTON (0480-3667-22) / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19)